This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1981 Aug;15(8):1117-22.

doi: 10.1203/00006450-198108000-00009.

Assessments of the sensitivities of cultured human neuroblastoma cells to anti-tumour drugs

B T Hill, R D Whelan

PMID: 7267186
DOI: 10.1203/00006450-198108000-00009

Assessments of the sensitivities of cultured human neuroblastoma cells to anti-tumour drugs

B T Hill et al. Pediatr Res. 1981 Aug.

. 1981 Aug;15(8):1117-22.

doi: 10.1203/00006450-198108000-00009.

Authors

B T Hill, R D Whelan

PMID: 7267186
DOI: 10.1203/00006450-198108000-00009

No abstract available

PubMed Disclaimer

Similar articles

In vitro evaluation of anticancer drugs with the human tumor stem cell assay.
Salmon SE, Von Hoff DD. Salmon SE, et al. Semin Oncol. 1981 Dec;8(4):377-85. Semin Oncol. 1981. PMID: 6275552 No abstract available.
Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.
Ponthan F, Lindskog M, Karnehed N, Castro J, Kogner P. Ponthan F, et al. Oncol Rep. 2003 Sep-Oct;10(5):1587-92. Oncol Rep. 2003. PMID: 12883745
Murine neuroblastoma: further evaluation of the C1300 model with single antitumor agents.
Finklestein JZ, Tittle K, Meshnik R, Weiner J. Finklestein JZ, et al. Cancer Chemother Rep. 1975 Sep-Oct;59(5):975-83. Cancer Chemother Rep. 1975. PMID: 1203900
Recent advances in targeted anti-vasculature therapy: the neuroblastoma model.
Pastorino F, Di Paolo D, Loi M, Becherini P, Caffa I, Zorzoli A, Marimpietri D, Carosio R, Perri P, Montaldo PG, Brignole C, Pagnan G, Ribatti D, Allen TM, Ponzoni M. Pastorino F, et al. Curr Drug Targets. 2009 Oct;10(10):1021-7. doi: 10.2174/138945009789577954. Curr Drug Targets. 2009. PMID: 19663770 Review.
Ligand-targeted liposomal therapies of neuroblastoma.
Pastorino F, Marimpietri D, Brignole C, Di Paolo D, Pagnan G, Daga A, Piccardi F, Cilli M, Allen TM, Ponzoni M. Pastorino F, et al. Curr Med Chem. 2007;14(29):3070-8. doi: 10.2174/092986707782793916. Curr Med Chem. 2007. PMID: 18220743 Review.

See all similar articles

Cited by

Phase I and II study of AMSA in childhood tumours.
Goldman A, Malpas JS. Goldman A, et al. Cancer Chemother Pharmacol. 1982;9(1):53-6. doi: 10.1007/BF00296763. Cancer Chemother Pharmacol. 1982. PMID: 6958393
9-cis retinoic acid--a better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma.
Lovat PE, Irving H, Malcolm AJ, Pearson AD, Redfern CP. Lovat PE, et al. J Neurooncol. 1997 Jan;31(1-2):85-91. doi: 10.1023/a:1005785431343. J Neurooncol. 1997. PMID: 9049833
Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line.
Hepburn PJ, Oliver RT, Riley PA, Hill BT, Masters JR. Hepburn PJ, et al. Urol Res. 1985;13(1):27-34. doi: 10.1007/BF00571753. Urol Res. 1985. PMID: 4039488
Implications for clinical pharmacodynamic studies of the statistical characterization of an in vitro antiproliferation assay.
Levasseur LM, Faessel H, Slocum HK, Greco WR. Levasseur LM, et al. J Pharmacokinet Biopharm. 1998 Dec;26(6):717-33. doi: 10.1023/a:1020755124451. J Pharmacokinet Biopharm. 1998. PMID: 10485082
The British Association for Cancer Research, 23rd annual general meeting. Edinburgh 29--31 March 1982. Abstracts.
[No authors listed] [No authors listed] Br J Cancer. 1982 Sep;46(3):459-516. doi: 10.1038/bjc.1982.227. Br J Cancer. 1982. PMID: 7126433 Free PMC article. No abstract available.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information